Use of sofosbuvir-based direct-acting antiviral therapy for hepatitis C viral infection in patients with severe renal insufficiency.
about
Efficacy and safety of direct-acting antivirals-based antiviral therapies for hepatitis C virus patients with stage 4-5 chronic kidney disease: a meta-analysis.Treatment of hepatitis C virus infection for adults and children: Updated Swedish consensus recommendations.Safety of direct antiviral agents in the management of hepatitis C.Drug interactions between buprenorphine, methadone and hepatitis C therapeutics.Safety of oral direct acting antiviral regimens for chronic hepatitis C in real life conditions.Sofosbuvir plus simeprevir for the treatment of genotype 1 chronic hepatitis C: a review of evidence.Use of direct-acting agents for hepatitis C virus-positive kidney transplant candidates and kidney transplant recipients.Management of Post-Liver Transplant Recurrence of Hepatitis C.Special populations: treating hepatitis C in patients with decompensated cirrhosis and/or advanced renal impairment.Novel Treatment of Hepatitis C Virus Infection for Patients with Renal Impairment.DAA-based antiviral treatment of patients with chronic hepatitis C in the pre- and postkidney transplantation setting.Sofosbuvir-based treatment is safe and effective in patients with chronic hepatitis C infection and end stage renal disease: a case series.Combination of sofosbuvir and daclatasvir in the treatment of genotype 3 chronic hepatitis C virus infection in patients on maintenance hemodialysis.Treatment of hepatitis C virus infection: updated Swedish Guidelines 2016.Safety and efficacy of sofosbuvir-containing regimens in hepatitis C-infected patients with impaired renal function.Ledipasvir and Sofosbuvir for untreated HCV genotype 1 infection in end stage renal disease patients: A prospective observational study.Contemporary Management of Hepatitis C in Patients with CKD.Hemodialysis Patients Treated for Hepatitis C Using a Sofosbuvir-based Regimen.Efficacy and safety of ombitasvir/paritaprevir/ritonavir in dialysis patients with genotype 1b chronic hepatitis C.Sofosbuvir-based regimens for the treatment of chronic hepatitis C in severe renal dysfunction.Evolution of glomerular filtration rates and neutrophil gelatinase-associated lipocalin during treatment with direct acting antivirals.Sofosbuvir: A Potential Treatment for EbolaHepatitis C and renal transplantation in era of new antiviral agents
P2860
Q36220536-EAB33F4B-D93C-4BED-BBBF-A6D5015D3F27Q36519126-9F1BE7AB-B832-4CA6-98B3-4C9330AED98FQ38818416-9F210EE4-2792-4FCA-B4F7-EE2102CF00BCQ38824198-B8046616-70BF-493B-9A56-D25DE35D8960Q38875903-E76A3661-52F4-411F-87D2-74E1C1FDCE90Q38954096-D7AD0353-B9BA-43B8-A7A8-576975594A18Q38975165-E2A1283F-88AB-4D8C-A271-706F37AF0D53Q39017681-8E2A5742-6CB7-4C08-BB76-82C80EE7B215Q39067369-892E4F3F-B7B2-4CE7-8DA5-A58C1C438624Q39092977-C3FD7C58-DF46-4E75-BF9D-3F51E49BCF85Q39749560-9BB54BDF-EB7B-45A8-809B-CE0CA91BC0F5Q40043601-699938DB-15FC-4648-814F-1883D3CA13ABQ40089989-82BACBC2-1FA7-4E39-92C5-ADF9D5A0BAC1Q40292229-C86C91AC-7959-4D70-9B2C-20CA813A1D53Q40774514-71128BE7-D512-4F50-9B88-AA6BCDA488ADQ41925546-CAC44160-9B17-412C-9F87-B8B437C91411Q43041968-0451C4D5-A6FB-40B4-A2DA-8A3AD95ED759Q47108436-72167F52-371D-44E4-86C5-C99BEF11E18BQ50208930-0433FAF7-D2E3-4212-81BE-2697BD9C9272Q51754955-E6A466B2-7FDB-4616-A7F4-E49AB6159910Q54230120-3A4F7DE1-C596-4894-82C0-E7C3BFC90C48Q58576148-1A3104F0-406E-4389-844D-0B6B7937CEBCQ58792851-68962A57-5E14-42BE-84C4-A3E8E39C8AA5
P2860
Use of sofosbuvir-based direct-acting antiviral therapy for hepatitis C viral infection in patients with severe renal insufficiency.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Use of sofosbuvir-based direct ...... th severe renal insufficiency.
@ast
Use of sofosbuvir-based direct ...... th severe renal insufficiency.
@en
type
label
Use of sofosbuvir-based direct ...... th severe renal insufficiency.
@ast
Use of sofosbuvir-based direct ...... th severe renal insufficiency.
@en
prefLabel
Use of sofosbuvir-based direct ...... th severe renal insufficiency.
@ast
Use of sofosbuvir-based direct ...... th severe renal insufficiency.
@en
P2093
P2860
P1476
Use of sofosbuvir-based direct ...... th severe renal insufficiency.
@en
P2093
Gregory L Hundemer
Jessica Wisocky
Kathleen E Corey
Lawrence S Friedman
Meghan E Sise
Nneka Ufere
P2860
P304
P356
10.3109/23744235.2015.1078908
P577
2015-08-18T00:00:00Z